Mithramycin for Lung, Esophagus, and Other Chest Cancers

Clinical trial NCT01624090 · TERMINATED

Trial details

NCT number: NCT01624090
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Esophageal Cancer Mesothelioma Gastrointestinal Neoplasms Breast Cancer

Start date: 2012-09-06
Primary completion: 2019-08-20
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.